| Literature DB >> 18955368 |
Adam Burke1, Tony Kuo, Rick Harvey, Jun Wang.
Abstract
Introduction. International comparative research on traditional medicine (TM) offers a useful method for examining differences in patient characteristics and can provide insight into: (i) more universal characteristics which may cross cultures and international borders; (ii) unique characteristics influenced by regional/national factors; and (iii) cultural values of immigrant populations. To explore these issues TM patients from the United States and China were compared. Methods. Data collection took place at two TM college clinics. A convenience sample of 128 patients in China and 127 patients in the United States completed a 28-item questionnaire. Results. There was a marked similarity between the two patient groups in terms of the biological characteristics of age and gender. Musculoskeletal issues were the most common presenting complaints in the United States; while in China TM was used for a more diverse array of conditions. The majority of patients in both countries had initially used allopathic medicine (AM); significantly, more of the United States respondents stopped allopathic treatment after beginning traditional treatment. In comparing the two countries, patients in China were significantly more satisfied with AM and American patients significantly more satisfied with TM. In comparing the two medicines, the patient samples in both countries were significantly more satisfied with TM than AM. Discussion. Although treatment often originated with allopathic providers, many patients sought alternatives presumably to find the best solution to their problems. This tendency toward self-assignment suggests that a pluralistic healthcare system may provide the greatest satisfaction resulting from personal choice and improved outcomes.Entities:
Year: 2011 PMID: 18955368 PMCID: PMC3136226 DOI: 10.1093/ecam/nen065
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Distribution of select participant characteristics.
| Characteristics | United States (ACTCM) | China (CDUTCM) | ||
|---|---|---|---|---|
| Frequency | Percent | Frequency | Percent | |
| Age (years) | ||||
| 18–29 | 22 | 17.5 | 25 | 19.0 |
| 30–39 | 32 | 25.4 | 29 | 23.0 |
| 40–49 | 33 | 26.2 | 32 | 25.4 |
| 50–59 | 28 | 22.1 | 16 | 12.7 |
| 60–69+ | 11 | 8.8 | 25 | 19.9 |
| Gender | ||||
| Female | 78 | 61.9 | 77 | 61.1 |
| Male | 48 | 38.1 | 49 | 38.9 |
| Race/ethnicity | ||||
| Asian | 12 | 9.5 | 126 | 100.0 |
| White | 95 | 75.4 | 0 | 0.0 |
| Other | 19 | 15.2 | 0 | 0.0 |
| Education | ||||
| Primary/high school | 7 | 5.6 | 79 | 62.7 |
| College | 68 | 53.9 | 45 | 35.7 |
| Graduate school | 51 | 40.5 | 2 | 1.6 |
| Marital status | ||||
| Currently married | 20 | 18.5 | 105 | 83.3 |
| Single no partner | 54 | 50.0 | 2 | 1.6 |
| Living with partner | 23 | 21.3 | 1 | 0.8 |
| Divorced/widowed | 11 | 10.3 | 18 | 14.3 |
| Health status | ||||
| Poor | 9 | 7.1 | 25 | 19.8 |
| Fair | 28 | 22.2 | 72 | 57.1 |
| Good | 56 | 44.5 | 22 | 17.5 |
| Very good | 25 | 19.8 | 7 | 5.6 |
| Excellent | 8 | 6.4 | 0 | 0.0 |
| Nature of health concern | ||||
| Chronic | 97 | 85.1 | 77 | 72.0 |
| Acute | 17 | 14.9 | 30 | 28.0 |
| Initial AM | 81 | 39.4 | 69 | 46.6 |
| Continue AM | 42 | 49.5 | 60 | 49.1 |
Figure 1Most common presenting complaints for TM by country.
Comparing attitudes toward allopathic and traditional treatments between countries.
| United States (ACTCM) | China (CDUTCM) | ||||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD |
| |
| Perceived efficacy of AM | 1.42 | 1.11 | 2.08 | 0.97 | <.001 |
| Perceived efficacy of TM | 2.73 | 0.78 | 2.51 | 1.06 | .178 |
| Satisfaction with AM | 1.35 | 1.05 | 1.84 | 0.75 | <.001 |
| Satisfaction with TM | 3.33 | 0.63 | 2.59 | 0.77 | <.001 |
| Dissatisfaction AM—use TM | 2.50 | 1.38 | 2.67 | 1.44 | .173 |
| Intention to use TM future | 3.65 | 0.51 | 2.95 | 1.17 | <.001 |
aMann-Whitney U-test.
Comparing attitudes toward allopathic and traditional treatments within countries.
| Allopathic | Traditional | ||||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD |
| |
| Perceived efficacy (United States) | 1.42 | 1.11 | 2.73 | 0.78 | .000 |
| Perceived efficacy (China) | 2.08 | 0.97 | 2.51 | 1.06 | .030 |
| Satisfaction (United States) | 1.35 | 1.05 | 3.33 | 0.63 | .000 |
| Satisfaction (China) | 1.84 | 0.75 | 2.59 | 0.77 | .000 |
*Wilcoxin signed-rank test.